Chikileva, I.O.; Bruter, A.V.; Persiyantseva, N.A.; Zamkova, M.A.; Vlasenko, R.Y.; Dolzhikova, Y.I.; Shubina, I.Z.; Donenko, F.V.; Lebedinskaya, O.V.; Sokolova, D.V.;
et al. Anti-Cancer Potential of Transiently Transfected HER2-Specific Human Mixed CAR-T and NK Cell Populations in Experimental Models: Initial Studies on Fucosylated Chondroitin Sulfate Usage for Safer Treatment. Biomedicines 2023, 11, 2563.
https://doi.org/10.3390/biomedicines11092563
AMA Style
Chikileva IO, Bruter AV, Persiyantseva NA, Zamkova MA, Vlasenko RY, Dolzhikova YI, Shubina IZ, Donenko FV, Lebedinskaya OV, Sokolova DV,
et al. Anti-Cancer Potential of Transiently Transfected HER2-Specific Human Mixed CAR-T and NK Cell Populations in Experimental Models: Initial Studies on Fucosylated Chondroitin Sulfate Usage for Safer Treatment. Biomedicines. 2023; 11(9):2563.
https://doi.org/10.3390/biomedicines11092563
Chicago/Turabian Style
Chikileva, Irina O., Alexandra V. Bruter, Nadezhda A. Persiyantseva, Maria A. Zamkova, Raimonda Ya. Vlasenko, Yuliya I. Dolzhikova, Irina Zh. Shubina, Fedor V. Donenko, Olga V. Lebedinskaya, Darina V. Sokolova,
and et al. 2023. "Anti-Cancer Potential of Transiently Transfected HER2-Specific Human Mixed CAR-T and NK Cell Populations in Experimental Models: Initial Studies on Fucosylated Chondroitin Sulfate Usage for Safer Treatment" Biomedicines 11, no. 9: 2563.
https://doi.org/10.3390/biomedicines11092563
APA Style
Chikileva, I. O., Bruter, A. V., Persiyantseva, N. A., Zamkova, M. A., Vlasenko, R. Y., Dolzhikova, Y. I., Shubina, I. Z., Donenko, F. V., Lebedinskaya, O. V., Sokolova, D. V., Pokrovsky, V. S., Fedorova, P. O., Ustyuzhanina, N. E., Anisimova, N. Y., Nifantiev, N. E., & Kiselevskiy, M. V.
(2023). Anti-Cancer Potential of Transiently Transfected HER2-Specific Human Mixed CAR-T and NK Cell Populations in Experimental Models: Initial Studies on Fucosylated Chondroitin Sulfate Usage for Safer Treatment. Biomedicines, 11(9), 2563.
https://doi.org/10.3390/biomedicines11092563
